You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK – Exact Sciences said today that it has received approval from the US Food and Drug Administration to expand the indication for its Cologuard colorectal cancer test to average-risk individuals aged 45 and older.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.